Medytox Solutions, Inc. 4
4 · Medytox Solutions, Inc. · Filed Mar 20, 2014
Insider Transaction Report
Form 4
Mendolia Thomas Francis DO
CEO of Company Laboratories10% Owner
Transactions
- Award
Restricted Stock
2014-03-13+30,000→ 30,000 total
Holdings
- 1,000
Series B Non-Convertible Preferred Stock
- 4,500,000
Common Stock
Footnotes (1)
- [F1]This grant of restricted stock of Medytox Solutions, Inc. (the "Company") vests in full on September 13, 2014, subject to the reporting person's continued employment with the Company.